Cargando…
Diagnostic Accuracy of (18)F-PSMA-1007 PET/CT Imaging for Lymph Node Staging of Prostate Carcinoma in Primary and Biochemical Recurrence
Prostate-specific membrane antigen (PSMA)–ligand PET/CT is performed on patients with prostate cancer to stage the disease initially or to identify sites of recurrence after definitive therapy. On the basis of clinical results, (18)F-PSMA-1007 is a promising PSMA PET tracer, but detailed histologic...
Autores principales: | Sprute, Katharina, Kramer, Vasko, Koerber, Stefan A., Meneses, Manuel, Fernandez, Rene, Soza-Ried, Cristian, Eiber, Mathias, Weber, Wolfgang A., Rauscher, Isabel, Rahbar, Kambiz, Schaefers, Michael, Watabe, Tadashi, Uemura, Motohide, Naka, Sadahiro, Nonomura, Norio, Hatazawa, Jun, Schwab, Constantin, Schütz, Viktoria, Hohenfellner, Markus, Holland-Letz, Tim, Debus, Juergen, Kratochwil, Clemens, Amaral, Horacio, Choyke, Pete L., Haberkorn, Uwe, Sandoval, Camilo, Giesel, Frederik L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Nuclear Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679593/ https://www.ncbi.nlm.nih.gov/pubmed/32817141 http://dx.doi.org/10.2967/jnumed.120.246363 |
Ejemplares similares
-
Detection Efficacy of (18)F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
por: Giesel, Frederik L., et al.
Publicado: (2019) -
Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention
por: Loktev, Anastasia, et al.
Publicado: (2019) -
(68)Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers
por: Giesel, Frederik L., et al.
Publicado: (2019) -
FAPI-74 PET/CT Using Either (18)F-AlF or Cold-Kit (68)Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients
por: Giesel, Frederik L., et al.
Publicado: (2021) -
Enhancement of (211)At Uptake via the Sodium Iodide Symporter by the Addition of Ascorbic Acid in Targeted α-Therapy of Thyroid Cancer
por: Watabe, Tadashi, et al.
Publicado: (2019)